Company

Neumora Therapeutics, Inc.

Neumora develops precision medicine treatments for neuropsychiatric and neurodegenerative disorders.

About

Founded in Watertown in 2019, Neumora Therapeutics develops treatments for brain diseases using a precision medicine approach to target central nervous system pathways. The company completed an IPO in September 2023, raising USD 250 mn. CEO Henry Gosebruch leads the company.

2Funding rounds

14Investors

Sign in to see more

Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.

Sign in